Physician

Steven G Lin, M.D.

According to 2025 Medicare claims, Steven Lin, M.D. (NPI: 1457343568) practices ophthalmology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from Riverside, CA. This provider's primary affiliated billing organization is PACIFIC EYE INSTITUTE, A MEDICAL GROUP, INC. (NPI: 1962422709; TIN: 330303507) and primary practice location at 92211-6080.

Lin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 968 traditional Medicare patients, billed 39,933 HCPCS/CPT codes, and received $2,342,648 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,163 prescription claims across 243 beneficiaries totaling $102,280 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 17 records totaling $375. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $81,133 to $102,280. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.7M2015 Medicare payment: $1,904,162 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,998,826 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,475,363 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,637,698 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,744,621 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,351,459 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,295,511 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,453,049 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,545,115 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,342,648 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157309,056$1,904,162
20168339,195$1,998,826
201797512,316$2,475,363
20181,03212,966$2,637,698
201997312,957$2,744,621
202082110,761$2,351,459
202190410,681$2,295,511
20221,03014,339$2,453,049
202397732,640$2,545,115
202496839,933$2,342,648

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$89K$178K2015 Drug cost: $81,133 (USD; Tot_Drug_Cst)2016 Drug cost: $101,142 (USD; Tot_Drug_Cst)2017 Drug cost: $88,077 (USD; Tot_Drug_Cst)2018 Drug cost: $91,070 (USD; Tot_Drug_Cst)2019 Drug cost: $126,406 (USD; Tot_Drug_Cst)2020 Drug cost: $117,387 (USD; Tot_Drug_Cst)2021 Drug cost: $108,260 (USD; Tot_Drug_Cst)2022 Drug cost: $178,427 (USD; Tot_Drug_Cst)2023 Drug cost: $157,674 (USD; Tot_Drug_Cst)2024 Drug cost: $102,280 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153091,339$81,133
20163851,679$101,142
20173031,322$88,077
20183021,324$91,070
20192891,395$126,406
20202391,116$117,387
20212211,075$108,260
20222441,123$178,427
20232251,042$157,674
20242431,163$102,280

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2051,269$658
92014Established patient complete exam of visual system500730$96
67028Injection of drug into eye3371,309$89
92012Established patient problem focused exam of visual system7181,837$66
92134Imaging of retina9582,868$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium381,466$23,718
RhopressaNetarsudil Mesylate341,356$15,986
Bromfenac SodiumBromfenac Sodium471,822$14,419
Brimonidine TartrateBrimonidine Tartrate1488,855$7,851
RocklatanNetarsudil Mesylat/Latanoprost11674$7,553

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$375Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Steven G. Lin, M.D.?

Tedicare shows public-source Medicare data for Steven G. Lin, M.D. (NPI 1457343568), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven G. Lin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven G. Lin, M.D.?

Steven G. Lin, M.D. is linked to PACIFIC EYE INSTITUTE, A MEDICAL GROUP, INC. (billing NPI 1962422709) in the available physician profile data.

Does Steven G. Lin, M.D. have Open Payments data?

Steven G. Lin, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.